Evaluation of the antiviral effect of rifabutin in AIDS-related complex.
Torseth
J
J
Stanford University School of Medicine, CA 94305.
Bhatia
G
G
Harkonen
S
S
Child
C
C
Skinner
M
M
Robinson
W S
WS
Blaschke
T F
TF
Merigan
T C
TC
D000386:AIDS-Related Complex / Q000188:drug therapy*; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006678:HIV / Q000187:drug effects*; D015488:HIV Antigens / Q000032:analysis; D016655:HIV Core Protein p24; D006801:Humans; D008297:Male; D012191:Retroviridae Proteins / Q000032:analysis; D017828:Rifabutin; D012294:Rifamycins / Q000009:adverse effects / Q000627:therapeutic use*
D000998:Antiviral Agents; D015488:HIV Antigens; D016655:HIV Core Protein p24; D012191:Retroviridae Proteins; D012294:Rifamycins; D017828:Rifabutin